About the treatment
Adaptive Detox Apheresis employs a double-cascade plasma filtration system in which separated plasma passes through sequential membranes with differing molecular weight cut-offs. This staged approach enables more selective removal of larger pathogenic or inflammatory macromolecules while minimising the loss of smaller essential proteins such as albumin and clotting factors.
The process is further refined through AI-assisted modelling that adjusts filtration parameters in real time according to the size, structure and concentration profiles of target molecules. Unlike conventional single-filter plasmapheresis, which applies a relatively blunt size threshold, this method allows finer discrimination and greater preservation of beneficial plasma constituents.
At Elysium the technique is used as a precision tool within personalised regenerative programmes. By reducing the circulating burden of selected inflammatory mediators, modified lipoproteins and other bioactive compounds, the therapy aims to restore a more favourable extracellular environment for cellular function and intercellular signalling.
The combination of cascade architecture and adaptive control represents a meaningful advance over earlier apheresis technologies and is particularly relevant for individuals whose biochemistry reflects the cumulative effects of modern environmental and metabolic stressors.
Treatments
